High antibacterial in vitro performance of gold nanoparticles synthesized by epigallocatechin 3-gallate
Source abstract
Abstract
In the present work, we report antibacterial activity of gold nanoparticles (AuNPs) prepared using Epigallocatechin 3-Gallate (EGCG) against S. aureus, E. faecalis, P. aeruginosa and E. coli. The synthesized AuNPs-EGCG showed optimal stability in physiological in vitro conditions and could be resuspended in various solvents. In vitro antibacterial activity against Gram-positive and Gram-negative bacteria was evidenced by inhibition of viable cell growth, with MIC values varying between 15 and 120 µg mL−1 in all treated bacteria. The antibacterial effects of the nanoformulation were the result of direct interaction with the surfaces of treated bacteria, causing morphological deformations that induced lysis and cell death. Besides, in vitro cytotoxicity analyses in murine fibroblast cells (L929) and human keratinocytes (HaCaT) showed high cell viability levels after 24 h of treatment with AuNPs-EGCG, with IC50 values of 267.55 e 293.04 µg mL−1, respectively. Thus, in its adsorbed form in gold nanoparticles, EGCG had its antibacterial activity potentiated and was less cytotoxic. AuNPs-EGCG shows high potential for future biomedical applications as an antibacterial treatment against skin infections. Schematic illustration of the synthesis of gold nanoparticles using EGCG (AuNPs-EGCG), its toxic application in gram-positive and -negative bacteria and its possible mechanism by inducing structural deformations.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Tea Polyphenols and Effects · Nanoparticles: synthesis and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (65)
Show source-provided references
1. K. Talkington, How to combat antibiotic resistance : 5 Priories for 2020, 2020.
2. A. Carminati, N. Jurado-campos, C. Rubio-escudero, I.A. Nepomuceno-chamorro, Bacterial resistance algorithm. An application to CVRP. Bioinspired Syst. Biomed. Appl. Mach. Learn. 11487, 137–145 (2019). https://doi.org/10.1007/978-3-030-19651-610.1007/978-3-030-19651-6 ↗
3. R.R. Watkins, R.A. Bonomo, Overview: global and local impact of antibiotic resistance. Infect. Dis. Clin. N. Am. 30, 313–322 (2016). https://doi.org/10.1016/j.idc.2016.02.00110.1016/j.idc.2016.02.001 ↗
4. M. Gajdács, F. Albericio, Antibiotic resistance: from the bench to patients. Antibiotics 8, 8–11 (2019). https://doi.org/10.3390/antibiotics803012910.3390/antibiotics8030129 ↗
5. K. Kalantari, E. Mostafavi, A.M. Afifi, Z. Izadiyan, H. Jahangirian, R. Rafiee-Moghaddam, T.J. Webster, Wound dressings functionalized with silver nanoparticles: promises and pitfalls. Nanoscale 12, 2268–2291 (2020). https://doi.org/10.1039/c9nr08234d10.1039/c9nr08234d ↗
6. G. Franci, A. Falanga, S. Galdiero, L. Palomba, M. Rai, G. Morelli, M. Galdiero, Silver nanoparticles as potential antibacterial agents. Molecules 20, 8856–8874 (2015). https://doi.org/10.3390/molecules2005885610.3390/molecules20058856 ↗
7. S. Thangudu, S.S. Kulkarni, R. Vankayala, C.S. Chiang, K.C. Hwang, Photosensitized reactive chlorine species-mediated therapeutic destruction of drug-resistant bacteria using plasmonic core-shell Ag@AgCl nanocubes as an external nanomedicine. Nanoscale 12, 12970–12984 (2020). https://doi.org/10.1039/d0nr01300e10.1039/d0nr01300e ↗
8. N. Iki, Silver nanoparticles. Anal. Sci. 34, 1223–1224 (2018). https://doi.org/10.2116/analsci.highlights181110.2116/analsci.highlights1811 ↗
9. Y.C. Yeh, B. Creran, V.M. Rotello, Gold nanoparticles: preparation, properties, and applications in bionanotechnology. Nanoscale 4, 1871–1880 (2012). https://doi.org/10.1039/c1nr11188d10.1039/c1nr11188d ↗
10. A. Singh, P.K. Gautam, A. Verma, V. Singh, P.M. Shivapriya, S. Shivalkar, A.K. Sahoo, S.K. Samanta, Green synthesis of metallic nanoparticles as effective alternatives to treat antibiotics resistant bacterial infections: a review. Biotechnol. Rep. 25, e00427 (2020). https://doi.org/10.1016/j.btre.2020.e0042710.1016/j.btre.2020.e00427 ↗
11. K.S. Merza, H.D. Al-Attabi, Z.M. Abbas, H.A. Yusr, Comparative study on methods for preparation of gold nanoparticles. Green Sustain. Chem. 02, 26–28 (2012). https://doi.org/10.4236/gsc.2012.2100510.4236/gsc.2012.21005 ↗
12. S. Balasubramanian, S.M.J. Kala, T.L. Pushparaj, P.V. Kumar, H. Katas, C.S. Lim, A.Y.H. Nor Azlan, F. Buang, M.F. Mh Busra, E.A. Ortiz-Benítez, N. Velázquez-Guadarrama, N.V. Durán Figueroa, H. Quezada, J. De Jesús Olivares-Trejo, W. Chums-ard, D. Fawcett, C.C. Fung, G.E.J. Poinern, Biogenic synthesis of gold nanoparticles from waste watermelon and their antibacterial activity against Escherichia coli and Staphylococcus epidermidis. Saudi Pharm. J. 11, 1265–1276 (2019). https://doi.org/10.18203/2320-6012.ijrms2019287410.18203/2320-6012.ijrms20192874 ↗
13. A. Crozier, Plant Secondary Metabolites (2007). https://doi.org/10.1002/9780470988558.ch210.1002/9780470988558.ch2 ↗
14. D. Sharma, K.V. Kosankar, Green tea in green world an updated review. Pharmatutor 6, 09 (2018). https://doi.org/10.29161/pt.v6.i3.2018.910.29161/pt.v6.i3.2018.9 ↗
15. D.G. Nagle, D. Ferreira, Y.D. Zhou, Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives. Phytochemistry 67, 1849–1855 (2006). https://doi.org/10.1016/j.phytochem.2006.06.02010.1016/j.phytochem.2006.06.020 ↗
16. S.M. Chacko, P.T. Thambi, R. Kuttan, I. Nishigaki, Beneficial effects of green tea: a literature review. Chin. Med. 5, 1–9 (2010). https://doi.org/10.1186/1749-8546-5-1310.1186/1749-8546-5-13 ↗
17. L. Elbling, R.M. Weiss, O. Teufelhofer, M. Uhl, S. Knasmueller, R. Schulte-Hermann, W. Berger, M. Micksche, Green tea extract and (-)-epigallocatechin-3-gallate, the major tea catechin, exert oxidant but lack antioxidant activities. FASEB J. 19, 807–809 (2005). https://doi.org/10.1096/fj.04-2915fje10.1096/fj.04-2915fje ↗
18. C. Knidel, M.F. Pereira, D.H.F. Barcelos, D.C.O. Gomes, M.C.C. Guimarães, R.P. Schuenck, Epigallocatechin gallate has antibacterial and antibiofilm activity in methicillin resistant and susceptible Staphylococcus aureus of different lineages in non-cytotoxic concentrations. Nat. Prod. Res. (2019). https://doi.org/10.1080/14786419.2019.169857510.1080/14786419.2019.1698575 ↗
19. J. Steinmann, J. Buer, T. Pietschmann, E. Steinmann, Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea. Br. J. Pharmacol. 168, 1059–1073 (2013). https://doi.org/10.1111/bph.1200910.1111/bph.12009 ↗
20. P. Kalaiselvi, K. Rajashree, L. Bharathi Priya, V.V. Padma, Cytoprotective effect of epigallocatechin-3-gallate against deoxynivalenol-induced toxicity through anti-oxidative and anti-inflammatory mechanisms in HT-29 cells. Food Chem. Toxicol. 56, 110–118 (2013). https://doi.org/10.1016/j.fct.2013.01.04210.1016/j.fct.2013.01.042 ↗
21. B.N. Singh, S. Shankar, R.K. Srivastava, Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem. Pharmacol. 82, 1807–1821 (2011). https://doi.org/10.1038/jid.2014.37110.1038/jid.2014.371 ↗
22. O. Krupkova, S.J. Ferguson, K. Wuertz-Kozak, Stability of (-)-epigallocatechin gallate and its activity in liquid formulations and delivery systems. J. Nutr. Biochem. 37, 1–12 (2016). https://doi.org/10.1016/j.jnutbio.2016.01.00210.1016/j.jnutbio.2016.01.002 ↗
23. L. Zhang, S. Wu, D. Wang, X. Wan, J. Zhang, Epigallocatechin-3-gallate (EGCG) in or on nanoparticles: enhanced stability and bioavailability of EGCG encapsulated in nanoparticles or targeted delivery of gold nanoparticles coated with EGCG, in Handb. Nanotoxicology, Nanomedicine Stem Cell Use Toxicol. (2014), pp. 131–144. https://doi.org/10.1002/9781118856017.ch8.10.1002/9781118856017.ch8 ↗
24. G.P.D. Schuenck, Síntese e caracterização fisico-quimica de Nanoparticulas de ouro usando Epigalocatequina-3-galato (EGCG). Programa Pos-Graduação Em Biotecnol. (2018). https://doi.org/10.1017/CBO9781107415324.00410.1017/CBO9781107415324.004 ↗
25. H. Zhu, M. Du, M. Zou, C. Xu, N. Li, Y. Fu, Facile and green synthesis of well-dispersed Au nanoparticles in PAN nanofibers by tea polyphenols. J. Mater. Chem. 22, 9301–9307 (2012). https://doi.org/10.1039/c2jm16569d10.1039/c2jm16569d ↗
26. C.S. Robb, S.E. Geldart, J.A. Seelenbinder, P.R. Brown, Analysis of green tea constituents by HPLC-FTIR. J. Liq. Chromatogr. Relat. Technol. 25, 787–801 (2002). https://doi.org/10.1081/JLC-12000303610.1081/JLC-120003036 ↗
27. R. Radhakrishnan, H. Kulhari, D. Pooja, S. Gudem, S. Bhargava, R. Shukla, R. Sistla, Encapsulation of biophenolic phytochemical EGCG within lipid nanoparticles enhances its stability and cytotoxicity against cancer. Chem. Phys. Lipids 198, 51–60 (2016). https://doi.org/10.1016/j.chemphyslip.2016.05.00610.1016/j.chemphyslip.2016.05.006 ↗
28. J.S.W. Mak, S.A. Rutledge, R.M. Abu-Ghazalah, F. Eftekhari, J. Irizar, N.C.M. Tam, G. Zheng, A.S. Helmy, Recent developments in optofluidic-assisted Raman spectroscopy. Prog. Quantum Electron. 37, 1–50 (2013). https://doi.org/10.1016/j.pquantelec.2012.11.00110.1016/j.pquantelec.2012.11.001 ↗
29. G.K. Chandra, D.R. Tripathy, S. Dasgupta, A. Roy, Interaction of (-)-epigallocatechin gallate with lysozyme-conjugated silver nanoparticles. Appl. Spectrosc. 66, 744–749 (2012). https://doi.org/10.1366/11.0653310.1366/11.06533 ↗
30. A.-S.A.-M. Al-Sherbini, Solvatochromic behavior of gold nanoparticles in different solvents. Nano Sci. Nano Technol. 7, 147–155 (2013)
31. M.L. De Souza, P. Corio, Solvatochromism and ionochromism of the nile blue dye a through raman, infrared and uvvis spectroscopies. Quim. Nova. 42, 1091–1097 (2019). https://doi.org/10.21577/0100-4042.2017043210.21577/0100-4042.20170432 ↗
32. Z. Khan, S.A. Al-Thabaiti, A.Y. Obaid, Z.A. Khan, A.O. Al-Youbi, Effects of solvents on the stability and morphology of CTAB-stabilized silver nanoparticles. Colloids Surf. A 390, 120–125 (2011). https://doi.org/10.1016/j.colsurfa.2011.09.01510.1016/j.colsurfa.2011.09.015 ↗
33. J. Liu, C. Liang, X. Zhu, Y. Lin, H. Zhang, S. Wu, Understanding the solvent molecules induced spontaneous growth of uncapped tellurium nanoparticles. Sci. Rep. 6, 1–10 (2016). https://doi.org/10.1038/srep3263110.1038/srep32631 ↗
34. G. Rodríguez-Gattorno, D. Díaz, L. Rendón, G.O. Hernández-Segura, Metallic nanoparticles from spontaneous reduction of silver(I) in DMSO. Interaction between nitric oxide and silver nanoparticles. J. Phys. Chem. B. 106, 2482–2487 (2002). https://doi.org/10.1021/jp012670c10.1021/jp012670c ↗
35. P. Mulvaney, Surface plasmon spectroscopy of nanosized metal particles. Langmuir 12, 788–800 (1996). https://doi.org/10.1021/la950271110.1021/la9502711 ↗
36. M. Rasmusson, A. Routh, B. Vincent, Flocculation of microgel particles with sodium chloride and sodium polystyrene sulfonate as a function of temperature. Langmuir 20, 3536–3542 (2004). https://doi.org/10.1021/la049913n10.1021/la049913n ↗
37. S. Francis, K.M. Nair, N. Paul, E.P. Koshy, B. Mathew, Green synthesized metal nanoparticles as a selective inhibitor of human osteosarcoma and pathogenic microorganisms. Mater. Today Chem. 13, 128–138 (2019). https://doi.org/10.1016/j.mtchem.2019.04.01310.1016/j.mtchem.2019.04.013 ↗
38. M.P. Patil, Y.B. Seo, H.K. Lim, G. Do Kim, Biofabrication of gold nanoparticles using Agrimonia pilosa extract and their antioxidant and cytotoxic activity. Green Chem. Lett. Rev. 12, 208–216 (2019). https://doi.org/10.1080/17518253.2019.162392710.1080/17518253.2019.1623927 ↗
39. A. Boldeiu, M. Simion, I. Mihalache, A. Radoi, M. Banu, P. Varasteanu, P. Nadejde, E. Vasile, A. Acasandrei, R.C. Popescu, D. Savu, M. Kusko, Comparative analysis of honey and citrate stabilized gold nanoparticles: in vitro interaction with proteins and toxicity studies. J. Photochem. Photobiol. B 197, 111519 (2019). https://doi.org/10.1016/j.jphotobiol.2019.11151910.1016/j.jphotobiol.2019.111519 ↗
40. T.S. Dasari, Y. Zhang, H. Yu, Antibacterial activity and cytotoxicity of gold (I) and (III) ions and gold nanoparticles. Biochem. Pharmacol. 4, 199 (2015). https://doi.org/10.1016/j.physbeh.2017.03.04010.1016/j.physbeh.2017.03.040 ↗
41. T.L. Botha, T.E. James, V. Wepener, Comparative aquatic toxicity of gold nanoparticles and ionic gold using a species sensitivity distribution approach. J. Nanomater. 2015, 1–16 (2015). https://doi.org/10.1155/2015/98690210.1155/2015/986902 ↗
42. S. Chaicherd, M.C. Killingsworth, D. Pissuwan, Toxicity of gold nanoparticles in a commercial dietary supplement drink on connective tissue fibroblast cells. SN Appl. Sci. (2019). https://doi.org/10.1007/s42452-019-0354-210.1007/s42452-019-0354-2 ↗
43. D. Kumar Ban, S. Paul, Functionalized gold and silver nanoparticles modulate amyloid fibrillation, defibrillation and cytotoxicity of lysozyme via altering protein surface character. Appl. Surf. Sci. 473, 373–385 (2019). https://doi.org/10.1016/j.apsusc.2018.12.15710.1016/j.apsusc.2018.12.157 ↗
44. D. Pissuwan, C.H. Cortie, S.M. Valenzuela, M.B. Cortie, Functionalised gold nanoparticles for controlling pathogenic bacteria. Trends Biotechnol. 28, 207–213 (2010). https://doi.org/10.1016/j.tibtech.2009.12.00410.1016/j.tibtech.2009.12.004 ↗
45. M.M. Mohamed, S.A. Fouad, H.A. Elshoky, G.M. Mohammed, T.A. Salaheldin, Antibacterial effect of gold nanoparticles against Corynebacterium pseudotuberculosis. Int. J. Vet. Sci. Med. 5, 23–29 (2017). https://doi.org/10.1016/j.ijvsm.2017.02.00310.1016/j.ijvsm.2017.02.003 ↗
46. M.F. Zawrah, S.I. Abd El-Moez, Antimicrobial activities of gold nanoparticles against major foodborne pathogens. Life Sci. J. 8, 37–44 (2011)
47. N. Naimi-Shamel, P. Pourali, S. Dolatabadi, Green synthesis of gold nanoparticles using Fusarium oxysporum and antibacterial activity of its tetracycline conjugant. J. Mycol. Med. 29, 7–13 (2019). https://doi.org/10.1016/j.mycmed.2019.01.00510.1016/j.mycmed.2019.01.005 ↗
48. T. Roshmi, K.R. Soumya, M. Jyothis, E.K. Radhakrishnan, Effect of biofabricated gold nanoparticle-based antibiotic conjugates on minimum inhibitory concentration of bacterial isolates of clinical origin. Gold Bull. 48, 63–71 (2015). https://doi.org/10.1007/s13404-015-0162-410.1007/s13404-015-0162-4 ↗
49. C. Ando, K. Kono, I. Tatara, S. Takeda, K. Arakawa, HARA Y, Antibacterial activity of epigallocatechin gallate against Staphylococcus. Med. Bull. Fukuoka Univ. 26, 31–33 (1999)
50. G. Raju, N. Katiyar, S. Vadukumpully, S.A. Shankarappa, Penetration of gold nanoparticles across the stratum corneum layer of thick-Skin. J. Dermatol. Sci. 89, 146–154 (2018). https://doi.org/10.1016/j.jdermsci.2017.11.00110.1016/j.jdermsci.2017.11.001 ↗
51. P. Ghosh, G. Han, M. De, C.K. Kim, V.M. Rotello, Gold nanoparticles in delivery applications. Adv. Drug Deliv. Rev. 60, 1307–1315 (2008). https://doi.org/10.1016/j.addr.2008.03.01610.1016/j.addr.2008.03.016 ↗
52. E.R. Caudill, R. Tapia Hernandez, K.P. Johnson, J. O’Rourke, L. Zhu, C. Haynes, Z.V. Feng, J.A. Pedersen, Wall teichoic acids govern cationic gold nanoparticle interaction with gram-positive bacterial cell walls. Chem. Sci. (2020). https://doi.org/10.1039/c9sc05436g10.1039/c9sc05436g ↗
53. L. Mashburn-Warren, R.J.C. Mclean, M. Whiteley, Gram-negative outer membrane vesicles: beyond the cell surface. Geobiology. 6, 214–219 (2008). https://doi.org/10.1111/j.1472-4669.2008.00157.x10.1111/j.1472-4669.2008.00157.x ↗
54. M. Mahmoud, F. Alkhaleefah, D.M. Sherif, Antimicrobial effects of epigallocatechingallate and epicatechins of green tea on planktonic and biofilm forms of staphylococcus aureus, including MRSA. Nat. Sci. 11, 70–79 (2013)
55. A. Rai, A. Prabhune, C.C. Perry, Antibiotic mediated synthesis of gold nanoparticles with potent antimicrobial activity and their application in antimicrobial coatings. J. Mater. Chem. 20, 6789–6798 (2010). https://doi.org/10.1039/c0jm00817f10.1039/c0jm00817f ↗
56. F. Ding, P. Songkiatisak, P.K. Cherukuri, T. Huang, X.H.N. Xu, Size-dependent inhibitory effects of antibiotic drug nanocarriers against Pseudomonas aeruginosa. ACS Omega 3, 1231–1243 (2018). https://doi.org/10.1021/acsomega.7b0195610.1021/acsomega.7b01956 ↗
57. S.C. Hayden, G. Zhao, K. Saha, R.L. Phillips, X. Li, O.R. Miranda, V.M. Rotello, M.A. El-Sayed, I. Schmidt-Krey, U.H.F. Bunz, Aggregation and interaction of cationic nanoparticles on bacterial surfaces. J. Am. Chem. Soc. 134, 6920–6923 (2012). https://doi.org/10.1021/ja301167y10.1021/ja301167y ↗
58. V.D. Badwaik, L.M. Vangala, D.S. Pender, C.B. Willis, Z.P. Aguilar, M.S. Gonzalez, R. Paripelly, R. Dakshinamurthy, Size-dependent antimicrobial properties of sugarencapsulated gold nanoparticles synthesized by a green method. Nanoscale Res. Lett. 7, 1–11 (2012). https://doi.org/10.1186/1556-276X-7-62310.1186/1556-276X-7-623 ↗
59. C.C. Lin, Y.C. Yeh, C.Y. Yang, C.L. Chen, G.F. Chen, C.C. Chen, Y.C. Wu, Selective binding of mannose-encapsulated gold nanoparticles to type 1 pili in Escherichia coli. J. Am. Chem. Soc. 124, 3508–3509 (2002). https://doi.org/10.1021/ja020090310.1021/ja0200903 ↗
60. T. Mosmann, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55–63 (1983). https://doi.org/10.1016/0022-1759(83)90303-410.1016/0022-1759(83)90303-4 ↗
61. S. Shamaila, N. Zafar, S. Riaz, R. Sharif, J. Nazir, S. Naseem, Gold nanoparticles: an efficient antimicrobial agent against enteric bacterial human pathogen. Nanomaterials 6, 1–10 (2016). https://doi.org/10.3390/nano604007110.3390/nano6040071 ↗
62. CLSI, M07. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically Eleventh edition, CLSI Doc. M07-A11. (2018) 112.
63. M.J. Pelczar Junior, E.C.S. Chan, N.R. Krieg, Microbiologia:conceitos e Aplicaçõesconceitos e Aplicações, 2nd edn. (Makron Books, São Paulo, 1996).
64. S.P. Gorman, E.M. Scott, A.D. Russell, Antimicrobial activity, uses and mechanism of action of glutaraldehyde. J. Appl. Bacteriol. 48, 161–190 (1980). https://doi.org/10.1111/j.1365-2672.1980.tb01217.x10.1111/j.1365-2672.1980.tb01217.x ↗
65. C.M. Mann, J.L. Markham, A new method for determining the minimum inhibitory concentration of essential oils. J. Appl. Microbiol. 84, 538–544 (1998). https://doi.org/10.1046/j.1365-2672.1998.00379.x10.1046/j.1365-2672.1998.00379.x ↗